Chemical businesses across the UK have stressed the importance of an improving European Union economy to their UK manufacturing operations.
The Biological Products Industry Alliance (BPIA), a rapidly growing US-based trade association representing the biopesticides and biostimulants industries, will be holding a Sustainability Symposium in Orlando, Florida on 11th October 2017. Focusing on the role of biological products in sustainability, the symposium is for biological products manufacturers and marketers, distributors, food processors, growers, and service providers supporting agriculture, public health, forestry, and specialty markets such as home and garden, turf and ornamentals, and structural pest control.
Air Products has reinforced its position as one of the world’s leading industrial gas companies with the successful completion of a multi-million upgrade to its gas production facility in Carrington, Manchester (UK), which is already onstream.
BASF has been recognised for the innovative development of its Irgastab PUR 70 antioxidant for polyurethane foam at the annual European Association of Flexible Polyurethane Foam Manufacturers (EUROPUR & EURO-MOLDERS) event, held in Milan, Italy.
For globally-acting companies, REACH is not the only regulatory challenge – it’s just the tip of the iceberg. Knoell´s conference on global chemical regulations provided an overview about the recent status and developments in chemical regulations, particularly in Asia and the Americas.
This event features conference presentations covering market trends in the agrochemical and speciality chemical industries, alongside more than 225 exhibitor displays and company showcase presentations.
In the first week of July, the FDA released a statement by its Commissioner Scott Gottlieb, MD, on the importance of the Drug Quality and Security Act and overseeing the safety of compounded drugs. A copy of the statement is provided below. Statement by FDA Commissioner, Dr Scott Gottlieb
The 48th Silicon Symposium returned to Philadelphia in June to continue the long tradition of connecting academia and industry, and to discuss latest developments and new applications in silicon chemistry.
Johnson Matthey, a global leader in science that enables cleaner air, improved health and more efficient use of natural resources, and Intrexon, a leader in the engineering and industrialization of biology, have entered into an exclusive collaboration to focus on the development of fermentation processes to produce peptide-based APIs. Peptide-based active pharmaceutical ingredients (APIs) are used as highly effective treatments in numerous therapeutic classes. However due to their structural complexity, peptides are costly and difficult to produce, requiring specialized equipment and reagents, and lengthy synthetic sequences with low chemical yields. To address this, Intrexon will focus on strain generation, utilizing its proprietary microbial hosts, initial fermentation and downstream isolation and purification. Subsequently, Johnson Matthey will be responsible for product scale-up and commercialization, ultimately developing much more efficient and effective processes for peptide-based drugs.
Flamma, a family-owned CMO that develops, manufactures, and commercializes small molecule active pharmaceutical ingredients (APIs) for the pharmaceutical industry, celebrated the Grand Opening of its new cGMP workshop and R&D Centre in Dalian, China on 19th June.